title: Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.
authors.forename: Alexander J
authors.initials: AJ
authors.lastname: Thompson
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Muir
authors.forename: Mark S
authors.initials: MS
authors.lastname: Sulkowski
authors.forename: Keyur
authors.initials: K
authors.lastname: Patel
authors.forename: Hans L
authors.initials: HL
authors.lastname: Tillmann
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Clark
authors.forename: Susanna
authors.initials: S
authors.lastname: Naggie
authors.forename: Jacques
authors.initials: J
authors.lastname: Fellay
authors.forename: Dongliang
authors.initials: D
authors.lastname: Ge
authors.forename: Jeanette J
authors.initials: JJ
authors.lastname: McCarthy
authors.forename: David B
authors.initials: DB
authors.lastname: Goldstein
authors.forename: John G
authors.initials: JG
authors.lastname: McHutchison
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods*; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007372:Interferons; D007378:Interleukins / Q000235:genetics*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D000095022:Interferon Lambda
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D007372:Interferons; D007378:Interleukins; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; C000624353:interferon-lambda, human; D000095022:Interferon Lambda; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a